[
  {
    "ts": null,
    "headline": "Better Buy in 2026: Pfizer or Eli Lilly?",
    "summary": "These two stocks have been going in opposite directions over the past few years.",
    "url": "https://finnhub.io/api/news?id=acaa472cde15f355f390181bb13a4c55de7d3b3f39d520541f285e2872a0c3f9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766077500,
      "headline": "Better Buy in 2026: Pfizer or Eli Lilly?",
      "id": 137825227,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "These two stocks have been going in opposite directions over the past few years.",
      "url": "https://finnhub.io/api/news?id=acaa472cde15f355f390181bb13a4c55de7d3b3f39d520541f285e2872a0c3f9"
    }
  },
  {
    "ts": null,
    "headline": "3 Cancer Stocks to Buy Amid Rapid Advances in Cancer Treatment",
    "summary": "J&J, ImmunityBio and Foghorn Therapeutics stand out as oncology players amid rapid innovation in cancer care with advancing pipelines, approvals and partnerships.",
    "url": "https://finnhub.io/api/news?id=5726ca2ccdc787ed320a3850e679a9b9333a7f4ca24f8d2b6ffb615ba7be8661",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766072400,
      "headline": "3 Cancer Stocks to Buy Amid Rapid Advances in Cancer Treatment",
      "id": 137825231,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "J&J, ImmunityBio and Foghorn Therapeutics stand out as oncology players amid rapid innovation in cancer care with advancing pipelines, approvals and partnerships.",
      "url": "https://finnhub.io/api/news?id=5726ca2ccdc787ed320a3850e679a9b9333a7f4ca24f8d2b6ffb615ba7be8661"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts",
    "summary": "NEW YORK, December 18, 2025--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EST on Tuesday, February 3, 2026. The purpose of the call is to provide an update on Pfizer’s results, as reflected in the company’s Fourth Quarter and Full Year 2025 Performance Report, to be issued that morning.",
    "url": "https://finnhub.io/api/news?id=0516c03e376c40d27f462688339ce9fbd4d4e366bb589f5d7d54af40a88bda3c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766070000,
      "headline": "Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts",
      "id": 137825411,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "NEW YORK, December 18, 2025--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EST on Tuesday, February 3, 2026. The purpose of the call is to provide an update on Pfizer’s results, as reflected in the company’s Fourth Quarter and Full Year 2025 Performance Report, to be issued that morning.",
      "url": "https://finnhub.io/api/news?id=0516c03e376c40d27f462688339ce9fbd4d4e366bb589f5d7d54af40a88bda3c"
    }
  },
  {
    "ts": null,
    "headline": "Morgan Stanley Maintains Pfizer (PFE) Equal-Weight Recommendation",
    "summary": "Morgan Stanley Maintains Pfizer (PFE) Equal-Weight Recommendation",
    "url": "https://finnhub.io/api/news?id=72c374b4218db760c8a8e2f91f05638725078a3af54d998126ebc2b1a9419cea",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766016247,
      "headline": "Morgan Stanley Maintains Pfizer (PFE) Equal-Weight Recommendation",
      "id": 137815234,
      "image": "",
      "related": "PFE",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=72c374b4218db760c8a8e2f91f05638725078a3af54d998126ebc2b1a9419cea"
    }
  }
]